ID: ALA97050

Max Phase: Preclinical

Molecular Formula: C15H8O6

Molecular Weight: 284.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1oc2cc(O)ccc2c2oc3cc(O)c(O)cc3c12

Standard InChI:  InChI=1S/C15H8O6/c16-6-1-2-7-11(3-6)21-15(19)13-8-4-9(17)10(18)5-12(8)20-14(7)13/h1-5,16-18H

Standard InChI Key:  QDAPIVLPJVTIAZ-UHFFFAOYSA-N

Associated Targets(Human)

Creatine kinase M 67 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 284.22Molecular Weight (Monoisotopic): 284.0321AlogP: 2.81#Rotatable Bonds: 0
Polar Surface Area: 104.04Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.09CX Basic pKa: CX LogP: 2.09CX LogD: 1.58
Aromatic Rings: 4Heavy Atoms: 21QED Weighted: 0.34Np Likeness Score: 1.34

References

1. da Silva AJM, Melo PA, Silva NM, Brito FV, Buarque CD, de Souza DV, Rodrigues VP, Poças ES, Noël F, Albuquerque EX, Costa PR..  (2001)  Synthesis and preliminary pharmacological evaluation of coumestans with different patterns of oxygenation.,  11  (3): [PMID:11212092] [10.1016/s0960-894x(00)00621-1]

Source